[1]
Schilcher, J. et al. 2015. Risk of atypical femoral fracture during and after bisphosphonate use. Acta Orthopaedica. 86, 1 (Jan. 2015), 100–107. DOI:https://doi.org/10.3109/17453674.2015.1004149.